Meta First Invest
  • Politics
  • Investing
  • Tech News
  • Stock
  • Editor’s Pick
Editor's Pick

Pfizer CEO says tariff uncertainty is deterring further U.S. investment in manufacturing, R&D

by admin April 30, 2025
by admin April 30, 2025 0 comment

Pfizer CEO Albert Bourla on Tuesday said uncertainty around President Donald Trump’s planned pharmaceutical tariffs is deterring the company from further investing in U.S. manufacturing and research and development. 

Bourla’s remarks on the company’s first-quarter earnings call came in response to a question about what Pfizer wants to see from tariff negotiations that would push the company to increase investments in the U.S. It comes as drugmakers brace for Trump’s levies on pharmaceuticals imported into the country — his administration’s bid to boost domestic manufacturing.

“If I know that there will not be tariffs … then there are tremendous investments that can happen in this country, both in R&D and manufacturing,” Bourla said on the call, adding that the company is also hoping for “certainty.”

“In periods of uncertainty, everybody is controlling their cost as we are doing, and then is very frugal with their investment, as we are doing, so that we are prepared for remit. So that’s what I want to see,” Bourla said.

Bourla noted the tax environment, which had previously pushed manufacturing abroad, has “significantly changed now” with the establishment of a global minimum tax of around 15%. He said that shift hasn’t necessarily made the U.S. more attractive, saying “it’s not as good” to invest here without additional incentives or clarity around tariffs.

“Now [Trump] I’m sure — and I know because I talked to him — that he would like to see even a reduction in the current tax regime particularly for locally produced goods,” Bourla said, adding a further decrease would be would be a strong incentive for manufacturing in the U.S.

Unlike other companies grappling with evolving trade policy, Pfizer did not revise its full-year outlook on Tuesday. However, the company noted in its earnings release that the guidance “does not currently include any potential impact related to future tariffs and trade policy changes, which we are unable to predict at this time.”

But on the earnings call on Tuesday, Pfizer executives said the guidance does reflect $150 million in costs from Trump’s existing tariffs.

“Included in our guidance that we didn’t really speak about is there are some tariffs in place today,” Pfizer CFO Dave Denton said on the call.

“We are contemplating that within our guidance range and we continue to again trend to the top end of our guidance range even with those costs to be incurred this year,” he said.

This post appeared first on NBC NEWS

0 comment
0
FacebookTwitterPinterestEmail
admin

previous post
Personalized Options Trading Strategies: Discover High-Yield Covered Calls and Spreads with the OptionsPlay Add-On
next post
Atlantic Appeals for Fiscal Re-evaluation for Ewoyaa Lithium Project

You may also like

Why Trump’s iPhone tariff threat might not be...

May 25, 2025

United Airlines reaches ‘industry-leading’ labor deal with flight...

May 24, 2025

Trump clears Nippon merger with U.S. Steel

May 24, 2025

How UnitedHealthcare became the face of America’s health...

May 23, 2025

Burger King targets families through movie partnerships in...

May 23, 2025

Target calls price hikes a ‘very last resort’...

May 22, 2025

A man once sued by the SEC wins...

May 22, 2025

Tariffs or not, a Chinese baby products company...

May 21, 2025

Levi Strauss to sell Dockers to brand management...

May 21, 2025

Cava revenue beats estimates as Mediterranean chain reports...

May 17, 2025
Join The Exclusive Subscription Today And Get Premium Articles For Free


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Recent Posts

  • Smarter Options Trading Starts Here! StockCharts + OptionsPlay

    May 28, 2025
  • Larry Williams on the Fed, Interest Rates & Markets! What’s Next?

    May 28, 2025
  • Investment Protection Agreement with the Ecuador Government on Challenger’s El Guayabo Project

    May 28, 2025
  • Phase 1 Drill Program – Operational and Geological Progress Update

    May 28, 2025
  • Crypto Market Review: Trump Media Planning US$3 Billion Raise to Buy Bitcoin, Other Coins

    May 27, 2025
  • About us
  • Contact us
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 metafirstinvest.com | All Rights Reserved

Meta First Invest
  • Politics
  • Investing
  • Tech News
  • Stock
  • Editor’s Pick